Savillex Corporation (“Savillex”), a leading provider of high-performance container and containment solutions for the life science industry, has announced the acquisition of Optimum Processing, a provider of single-use bioprocess products, including bottle assemblies, single use consumables, bioprocess bags, and custom assemblies. Together with Optimum Processing, Savillex has acquired a full suite of custom rigid container solutions for their most important and time-sensitive projects.
Founded in 1990 as a family-owned business, Optimum Processing focuses on designing and fabricating innovative single-use bioprocessing bags and systems. The designs are custom-made to the unique needs of each customer and used in a variety of life science use cases which require flexible and irradiated components, including cell culturing and manufacturing, vaccine production, and other diagnostic testing processes.
Savillex is a leader in providing high performance container and containment solutions for the life science industry, as well as semiconductor, aerospace, and geochemistry applications through Savillex, ONFAB, and Optimum Processing brands. Since its founding in 1976, Savillex’s goal has remained the same: to provide the world’s best container and containment solutions to users worldwide, whatever the application. Savillex is headquartered and has manufacturing facilities in Eden Prairie, Minnesota, USA and Middlewich, UK.
Thompson Street Capital Partners is a St. Louis-based private equity firm focused on investing in founder-led middle market businesses. TSCP has acquired more than 200 companies in the Life Sciences & Healthcare Services, Software & Technology and Business Services & Consumer Products sectors. TSCP partners with management teams to increase value by accelerating growth, both organically and via complementary acquisition.
EC M&A acted as exclusive financial advisor to Savillex on this transaction.